Aulisa Medical Announces The Launch Of The Guardian Angel ® Lite Plus Monitoring Products For İnfants And Adults

Aulisa Medical USA, Inc.

Aulisa Medical USA, Inc.,a Palo Alto, CA based pioneer in wearable, wireless, app-enabled continuous vital sign monitoring and alarm system technology has launched a new line of devices specifically intended for in-home use. The Guardian Angel® Lite Plus product line uses pulse oximetry to track heart rate and oxygen levels and is specifically focused on improving the form factor of the sensor for easier use, wearability and comfort.

“The need of consumers utilizing wearable devices to proactively monitor their own health and wellness as well as that of their loved ones is only growing stronger,” said founder and CEO Augustine (Augie) Lien. “Aulisa is deeply committed to innovating in this space as well as ensuring that our products always meet the highest safety and efficacy bar.”

Whether you are interested in monitoring your own vital signs, that of a new baby or older parent or loved one, the Guardian Angel ® Lite Plus product line is easy to use, wearable and comfortable to wear. The app-enabled continuous monitoring devices leverage artificial intelligence and digital health which continuously monitor heart rate (pulse) and oxygen saturation levels (SpO2), and alert users through customizable alarms to inconsistencies in vital sign data, enabling early detection and intervention for potentially adverse events.

Dr. Ross Sommers, of West Palm Beach, FL, a renowned neonatologist and founder of Firstday Healthcare, states:

“As a neonatologist and entrepreneur who is passionate about and dedicated to empowering parents with children who are managing complex medical conditions by providing home healthcare solutions, I am excited to partner with Aulisa® in bringing their Guardian Angel ® products to market.  There is a clear unmet need in at-home vital sign monitoring for infants, which not only give both parents and clinicians peace of mind but also have the potential to enable proactive intervention, ultimately reducing ER visits and hospital readmissions.  This is a positive step for parents, clinicians and the economics of our current healthcare system.”

CEVAP VER

Please enter your comment!
Please enter your name here